SCHEMBL7809018

SCHEMBL7809018

O=C(O)/C=C/c1ccccc1/C=C/C(O)c1ccccc1OCc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 12/20 0.68
PTGER2 P43116 12/20 0.68
PTGER3 P43115 12/20 0.68
PTGER1 P34995 7/20 0.68
KDM4E B2RXH2 2/20 0.48
LMNA P02545 1/20 0.48
HTT P42858 1/20 0.47
CCNB2 O95067 1/20 0.46
CDK1 P06493 1/20 0.46
CDK4 P11802 1/20 0.46
CCNB1 P14635 1/20 0.46
CCND1 P24385 1/20 0.46
CCNB3 Q8WWL7 1/20 0.46
PTGDR Q13258 1/20 0.46
AKR1C3 P42330 1/20 0.45
ALDH1A1 P00352 2/20 0.45
PKM P14618 1/20 0.44
LTB4R Q15722 1/20 0.43
LTB4R2 Q9NPC1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7809020 1.00 PTGER4 (0.68) PTGER4PTGER2PTGER3PTGER1KDM4E
SCHEMBL7957148 0.91 PTGER4 (0.55) PTGER4PTGER2PTGER3PTGER1KDM4E
SCHEMBL7798442 0.83 PTGER2 (0.79) PTGER4PTGER2PTGER3PTGER1KDM4E
SCHEMBL7798447 0.83 PTGER2 (0.79) PTGER4PTGER2PTGER3PTGER1KDM4E
SCHEMBL8323200 0.81 PTGER4 (0.94) PTGER4PTGER2PTGER3PTGER1KDM4E
SCHEMBL8323198 0.81 PTGER4 (0.94) PTGER4PTGER2PTGER3PTGER1KDM4E
SCHEMBL7968873 0.77 PTGER4 (0.84) PTGER4PTGER2PTGER3PTGER1KDM4E
SCHEMBL3114346 0.77 PTGER4 (0.74) PTGER4PTGER2PTGER3PTGER1KDM4E
SCHEMBL19511288 0.77 PTGER4 (0.74) PTGER4PTGER2PTGER3PTGER1KDM4E
SCHEMBL19511064 0.77 PTGER4 (0.74) PTGER4PTGER2PTGER3PTGER1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010031766-A1 Prostaglandin receptor ligands MERCK FROSST CANADA & CO. 2001-10-18 US disclosed
EP-1119542-A1 PROSTAGLANDIN RECEPTOR LIGANDS Merck Frosst Canada & Co. (CA) 2001-08-01 EP disclosed
WO-2000020371-A1 PROSTAGLANDIN RECEPTOR LIGANDS MERCK FROSST CANADA & CO. (CA) 2000-04-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031766-A1 Prostaglandin receptor ligands PTGER1, PTGER2, PTGFR PTGER4 11/4885PTGER2 2/4885PTGER3 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.